A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

NCT07266831 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

570

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Interventions

DRUG: ISL
DRUG: ULO
DRUG: BIC/FTC/TAF
DRUG: Placebo for BIC/FTC/TAF
DRUG: Placebo to ISL/ULO
DRUG: ISL/ULO

Sponsor

Merck Sharp & Dohme LLC